What HarborPath does

HarborPath is a U.S. national nonprofit organization founded in 2012 and headquartered in Charlotte, North Carolina, that delivers free life-saving medications to uninsured patients by aggregating multiple pharmaceutical manufacturer Patient Assistance Programs (PAPs) into a single, streamlined platform. The organization operates the harborpathpap.com portal, which consolidates applications across manufacturers including ViiV Healthcare, Merck, AbbVie, Janssen, Emergent BioSolutions, Padagis, and Vivus, reducing what would otherwise be a 5-to-1 application burden for case managers into a unified 15-minute workflow with 48-hour medication fulfillment versus a traditional 6-week timeline. HarborPath administers several distinct programs: the ADAP Waiting List Program (since May 2013) providing antiretroviral medications to HIV/AIDS patients on state waiting lists under the federal Ryan White Part B framework; the HarborPath Oncology PAP providing no-cost cancer medications across roughly a dozen cancer types; the Naloxone Right Now initiative distributing opioid reversal medications through public safety and community channels in partnership with FFF Enterprises; and the On Campus program partnering with universities (Ole Miss, Oklahoma) for fentanyl awareness and naloxone access using student-athlete NIL campaigns.

The business model is donation- and grant-funded, with operating revenue derived from individual donations, foundation grants, and government grants (e.g., Arkansas Attorney General), while medication inventory is sourced through pharmaceutical manufacturer donations. Patients receive medications at no cost subject to eligibility based on insurance status, U.S. residency, and income guidelines. Distribution channels span healthcare facilities (hospitals, clinics, case managers), university health centers, law enforcement and corrections agencies, school districts, and community organizations across 24 states. HarborPath's customer base is bifurcated: end patients and healthcare providers form a highly distributed long-tail, while upstream pharma manufacturer partners and grant/donor sources represent more concentrated counterparties critical to program capacity. Governance includes a Board of Directors (chaired by Dr. Donna Sweet, with Greg Weaver as Vice Chair) and a National Advisory Board formed in July 2025 to support expanded opioid response efforts.

Name

HarborPath

Legal name

HarborPath

Website

https://harborpath.org

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

HarborPath is a Charlotte-based nonprofit founded in 2012 that aggregates pharmaceutical patient assistance programs into a single portal to deliver free medications (HIV/AIDS, oncology, naloxone, diabetes, hepatitis C) to uninsured patients across 24 U.S. states, funded by manufacturer donations and grants.

Ownership category

akta.pro rank

Headquarters

HQ city

Charlotte

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. Donations and Grants: HarborPath is a nonprofit organization funded entirely through donations from individuals, foundations, and government grants. The company provided over $9 million in medications to uninsured patients in 2025, all at no cost to patients.
2. Arkansas Attorney General Grant: HarborPath received a grant from Arkansas Attorney General Tim Griffin to secure 5,680 Naloxone kits for Arkansas law enforcement and corrections officers.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels8 records

Core offering

HarborPath is a national nonprofit that aggregates multiple pharmaceutical manufacturer Patient Assistance Programs (PAPs) into a single online application platform, enabling healthcare providers to enroll uninsured U.S. patients and have free medications shipped within 48 hours. The organization also administers the ADAP Waiting List Program (HIV/AIDS), an Oncology PAP, and a Naloxone Distribution Program, all delivered at no cost to qualifying patients through donations and grants.

Product overview

HarborPath is a non-profit organization that delivers life-saving medication to the uninsured through patient assistance programs (PAPs). The core offering consists of the HarborPath Patient Assistance Program, which provides free medications across multiple disease states including HIV/AIDS, oncology, opioid response, diabetes, hepatitis C, high cholesterol, and anti-nausea support for chemotherapy patients. The organization operates the ADAP Waiting List Program for HIV/AIDS patients and the HarborPath Oncology PAP for cancer patients. Additional programs include naloxone distribution through the Naloxone Right Now initiative and the On Campus program partnering with universities for fentanyl awareness and prevention. Healthcare providers and case managers use an online portal to apply on behalf of patients, with medications shipped from HarborPath's pharmacy within 48 hours of approved documentation.

Differentiator

Problem solved

Functional benefit

Brands

• HarborPath Oncology PAP: Oncology Patient Assistance Program providing uninsured cancer patients with no-cost access to critical medications.
• ADAP Waiting List Program

Products and services

• HarborPath Patient Assistance Program (PAP)
• ADAP Waiting List Program
• HarborPath Oncology PAP
• Naloxone/Narcan Distribution Program (Naloxone Right Now)
• HarborPath On Campus Program
• Case Manager Portal (harborpathpap.com)

Quantifiable outcome

• Delivers medications in under 48 hours compared to up to 6 weeks for traditional patient assistance programs
• +5 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

19 partnerships are on record, tiered core, minor and major.

• ViiV HealthcarecoreStrategic or Co-development Partner · 1 January 2012Pharmaceutical manufacturer providing HIV/AIDS medications to HarborPath's patient assistance program, enabling free distribution to uninsured patients.
• MerckcoreStrategic or Co-development PartnerPharmaceutical manufacturer partner providing medications through HarborPath's patient assistance programs.
• AbbViecoreStrategic or Co-development PartnerPharmaceutical manufacturer partner providing medications to HarborPath's patient assistance programs.
• Janssen (Johnson & Johnson)coreStrategic or Co-development PartnerPharmaceutical manufacturer providing medications including HIV drugs and oncology treatments through HarborPath's patient assistance programs.
• Canine AssistantsminorStrategic or Co-development PartnerPartnership to raise awareness around epilepsy and seizure disorders. HarborPath is working with ambassador golden retriever KJ to help raise awareness and advocacy around epilepsy.
• FFF EnterprisescoreTechnology or IntegrationUtilizes FFF Enterprises' efficient inventory management and distribution technology to effectively distribute life-saving naloxone and other medications where needed most through the Naloxone Right Now initiative.
• PAARI (Police Assisted Addiction and Recovery Initiative)majorStrategic or Co-development PartnerPartnership with PAARI and FFF Enterprises to oversee a pilot program in Ohio beginning April 2023, supplying nasal Naloxone to participating public safety agencies for distribution to people at highest risk of opioid overdose.
• Operation UNITEmajorStrategic or Co-development PartnerPartnership to combat substance abuse in Eastern Kentucky through education, support, and life-saving resources. HarborPath established a prevention projects coordinator and is placing emergency response kits containing naloxone across eastern Kentucky in schools, housing, and community locations.
• University of OklahomamajorStrategic or Co-development PartnerLaunched awareness campaign in Fall 2025 combining access to free naloxone with student-athlete influence. Facilitated by Sooner Sports Properties and 1Oklahoma, supported by OU's Goddard Health Center for free naloxone distribution.
• University of MississippimajorStrategic or Co-development PartnerSpring 2024 partnership with Ole Miss, Attorney General Lynn Fitch, The Grove Collective, and the William Magee Center for fentanyl awareness and naloxone distribution campaign achieving over 600,000 social media impressions.
• Sooner Sports Properties / 1OklahomamajorGTM or Marketing PartnerFacilitated the HarborPath partnership with University of Oklahoma student-athletes for the On Campus awareness campaign.
• William Magee CentermajorStrategic or Co-development PartnerOle Miss center distributing free naloxone to students at the South Campus Recreation Center and providing fentanyl education resources.
• Seattle Fire DepartmentminorChannel Partner/ Reseller/ DistributorReceived donation of 1,000 dosages of intramuscular Naloxone from HarborPath for use in overdose response.
• Pike County SchoolsminorChannel Partner/ Reseller/ DistributorPilot program in partnership with FFF Enterprises to place Naloxone in homes of families in Eastern Kentucky through the school district.
• Washougal School DistrictminorChannel Partner/ Reseller/ DistributorReceived donation of Narcan from HarborPath to make naloxone more accessible to those who might need it.
• Emergent BioSolutionscoreStrategic or Co-development PartnerPharmaceutical manufacturer providing opioid reversal medications through HarborPath's programs.
• PadagiscoreStrategic or Co-development PartnerPharmaceutical manufacturer providing medications through HarborPath's patient assistance programs.
• TEMPOminorStrategic or Co-development PartnerPartnership providing opioid emergency response kits containing naloxone to live music venues in Nashville, TN metro area through the Gibson Gives TEMPO program.
• VivuscoreStrategic or Co-development PartnerPharmaceutical manufacturer providing medications through HarborPath's patient assistance programs.

Scale indicators14 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• PAN Foundation: Independent nonprofit providing financial assistance for out-of-pocket prescription medication costs. Comparable to HarborPath as a charitable safety net for patients who cannot afford life-saving medications.
• Rx Outreach: Nonprofit mail-order pharmacy providing affordable medications to uninsured and underinsured individuals across the U.S. Directly comparable to HarborPath as a charitable medication access organization serving low-income populations.
• NeedyMeds: Nonprofit information resource aggregating patient assistance programs and drug discount coupons. Comparable to HarborPath in aggregating PAP information for uninsured patients seeking free or low-cost medications.
• Patient Access Network (PAN) Foundation: Nonprofit providing financial assistance for out-of-pocket medication costs to underinsured patients with life-threatening, chronic, and rare diseases. Comparable to HarborPath in providing medication cost assistance, with a focus on copay rather than free PAP distribution.
• HealthWell Foundation: Nonprofit assisting underinsured patients with out-of-pocket costs for prescription drugs across more than 90 disease areas. Directly comparable to HarborPath as a safety-net medication access organization for underinsured and uninsured Americans.
• Dispensary of Hope: Nonprofit medication distributor connecting donated pharmaceuticals to uninsured patients through a network of charitable clinics and pharmacies. Comparable to HarborPath as a medication donation distribution intermediary serving safety-net populations.

Broad incumbents

• GoodRx: Public digital healthcare platform aggregating drug pricing, coupons, and telehealth services. Comparable to HarborPath as a consumer-facing medication access solution, though commercial and broader in scope rather than nonprofit-PAP focused.
• Pfizer RxPathways: Pfizer's comprehensive patient assistance program providing free or discounted Pfizer medications to eligible patients. Comparable as a large pharma manufacturer PAP, but single-sponsor rather than aggregating multiple manufacturers like HarborPath.
• Johnson & Johnson Patient Assistance Foundation: Independent nonprofit foundation providing Johnson & Johnson medications at no cost to eligible uninsured patients. Comparable to HarborPath's Janssen partnership as an established pharma-sponsored patient assistance program.

Others

• AmerisourceBergen / Cencora: Major pharmaceutical distributor providing logistics services that underpin many patient assistance and specialty pharmacy programs. Comparable to HarborPath as an enabling distribution partner in the medication access ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/harborpath
• LinkedInlinkedin.com/company/harborpath
• Instagraminstagram.com/harborpathinc
• Xx.com/harborpath

Revenue estimate

Valuation estimate

Number of profiles

Profiles19 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HarborPath